Please use this identifier to cite or link to this item: https://doi.org/10.1016/j.ajo.2003.08.036
Title: Surgical outcomes of combined phacoemulsification and glaucoma drainage implant surgery for Asian patients with refractory glaucoma with cataract
Authors: Chung, A.N.
Aung, T. 
Wang, J.-C.
Chew, P.T.K. 
Issue Date: 2004
Source: Chung, A.N., Aung, T., Wang, J.-C., Chew, P.T.K. (2004). Surgical outcomes of combined phacoemulsification and glaucoma drainage implant surgery for Asian patients with refractory glaucoma with cataract. American Journal of Ophthalmology 137 (2) : 294-300. ScholarBank@NUS Repository. https://doi.org/10.1016/j.ajo.2003.08.036
Abstract: • PURPOSE: To examine the safety and efficacy of combined phacoemulsification and glaucoma drainage implant surgery in providing reduction of intraocular pressure (IOP) and visual rehabilitation in eyes with refractory glaucoma and cataract. • DESIGN: Interventional case series. • METHODS: A retrospective chart review was performed on all subjects who underwent combined phacoemulsification with intraocular lens implantation and glaucoma drainage implant surgery by a single surgeon at the National University Hospital, Singapore. The implants used were the 185 mm2 Ahmed glaucoma valve and the 350 mm2 Baerveldt glaucoma implant. In terms of IOP, a complete success was defined as IOP of between 6 to 21 mm Hg without medication, qualified success as IOP between 6 to 21 mm Hg with one or more medication, and failure as a sustained IOP of >21 mm Hg or <6 mm Hg with or without one or more medication on two or more visits. • RESULTS: A total of 32 combined phacoemulsification and glaucoma implant surgeries in 32 patients was performed. All patients were of Asian origin, and the mean age was 58 ± 16 years (range, 20-78 years). The Baerveldt glaucoma implant and Ahmed glaucoma valve implant were inserted in 16 eyes each. With a mean follow-up of 13 ± 5 months (range 6 to 22 months), IOP was reduced from a mean of 28.0 ± 11.5 mm Hg to 15.2 ± 6.0 mm Hg postoperatively (P < .0001), whereas the number of antiglaucoma medications decreased from a mean of 2.4 ± 1.4 to .3 ± .7 (P < .0001) at last follow-up. Overall, there were 24 eyes (75%) that were classified as complete successes, 4 eyes (12.5%) that were qualified successes, and 4 eyes that failed (12.5%). Twenty-three eyes (72%) had improvement of visual acuity, while only one eye had a loss of more than 1 line of Snellen acuity. There was no case that encountered an intraoperative complication, and postoperative complications occurred in 12 eyes (38%), the most common of which was hypotony (in six eyes, 19%). • CONCLUSION: For subjects with refractory glaucoma and cataract, combined phacoemulsification and glaucoma drainage implant surgery provide good visual rehabilitation and control of IOP, with low incidence of complications. © 2004 by Elsevier Inc. All rights reserved.
Source Title: American Journal of Ophthalmology
URI: http://scholarbank.nus.edu.sg/handle/10635/29173
ISSN: 00029394
DOI: 10.1016/j.ajo.2003.08.036
Appears in Collections:Staff Publications

Show full item record
Files in This Item:
There are no files associated with this item.

SCOPUSTM   
Citations

15
checked on Dec 7, 2017

WEB OF SCIENCETM
Citations

12
checked on Nov 23, 2017

Page view(s)

187
checked on Dec 11, 2017

Google ScholarTM

Check

Altmetric


Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.